Tirzepatide Injectable

Patient Drug Information
Tirzepatide injectable
(Mounjaro® or Zepbound®)
Weight loss treatment

BPG-WL-TIR-BRAND-PIB-OHAZ02

About your prescription medication: Written information about this medication has been provided for you. Please read this information before you take this medication. If you have questions concerning this medication, a pharmacist is available during normal business hours to answer these questions.

Important Information: 

This should only be taken by the patient whose name appears on the prescription label.

Do not use tirzepatide if you are pregnant, planning to become pregnant, or currently breastfeeding.

• Active Ingredients
  • Tirzepatide is a a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycemic control in adults with type 2 diabetes and to aid in weight loss in certain adults.
    • Tizepatide’s most common side effects are constipation, diarrhea, nausea, vomiting, fatigue, headache, heartburn, upset stomach and/or stomach pain. Some patients have also reported feeling tired or weak, hair loss, and an increase in burping while using tirzepatide. Swelling or redness at the injection site may also occur.
    • Some patients may also experience pancreas or gallbladder problems while using tirzepatide. Stop using tirzepatide and seek emergent medical care if you have severe abdominal pain, with or without vomiting, that will not subside.

• Directions for Use
  • Inject subcutaneously once weekly. You may inject into the abdomen, front of your thigh, or the back of your arm. Rotate the site each week. Below is a diagram showing common injection sites.

• For detailed instructions on how to inject Mounjaro® and Zepbound® pens, please refer to the instructions for use enclosed in the box with your medication.
• Inspect your pen prior to injecting your weekly dose. The solution should be clear and colorless to slightly yellow. Do not use if particulate matter or discoloration is seen.

• After injecting, dispose of your used pen in a sharps disposal container. If you do not have one, you can use a plastic bin such as an empty milk jug or laundry detergent container.

• Pens and needles are for a single use only and should never be reused or shared with others.

• Storage
  • Store your Mounjaro® or  Zepbound® pens in the refrigerator between 36°F to 46°F (2°C to 8°C) in the packaging provided by the pharmacy until you need it. If necessary, the medication may be stored out of the refrigerator, up to 86°F (30°C) for up to 21 days.
  • Protect from freezing and light.
  • Keep out of reach of children.
  • Under certain circumstances a prescription drug’s effectiveness may be affected by exposure to extremes of heat, cold, humidity, or light exposure.

• Precautions and contraindications
  • Do not use this medication if you are allergic to any of the components.
  • Do not use tirzepatide if you are pregnant, planning to become pregnant, or currently breastfeeding.
  • Tirzepatide may decrease the effectiveness of oral birth control pills. Use an alternate form of birth control for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.

• Missed Dose
  • If you miss a dose of the medication, take it as soon as you remember within 4 days. If more than 4 days have passed, skip the missed dose entirely and resume your medication at the next scheduled weekly dose. Do not take extra medicine to make up for the missed dose. Check your prescription label for the correct dose prescribed by your medical provider.

Questions

This written information may not cover all possible information. If you have any questions, contact your pharmacist or medical provider.

You may also report adverse drug event reporting through the FDA website: www.fda.gov/medwatch and phone 1-800-FDA-1088.

A local or a toll-free telephone service is available, staffed by a registered pharmacist, to answer questions about your medication. You can find the number for the pharmacy on the label of your prescription product.

© 2025 Hims & Hers Health, Inc. All rights reserved. HIMS, HERS, H, and HIMS & HERS are trademarks of Hims, Inc.